Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 10 of 1714:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Gene Compound Assay Inh Ic50 Ki View
sodium channel, voltage-gated, type I, alpha CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type IX, alpha CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type VII, alpha CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
amiloride-sensitive cation channel 5, intestinal CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type III, beta CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type XI, alpha CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type I, beta CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type 10, alpha polypeptide CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type IV, alpha polypeptide CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type V, alpha polypeptide CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type II, beta CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, nonvoltage-gated 1 alpha CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, nonvoltage-gated 1 gamma CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, nonvoltage-gated 1 beta CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type XI, alpha CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, nonvoltage-gated 1, gamma CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, nonvoltage-gated 1, delta CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, nonvoltage-gated 1 alpha CLOMIPRAMINE Sodium Channel, Site 2 100% .742uM .677uM View
sodium channel, voltage-gated, type I, alpha FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type IX, alpha FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type VII, alpha FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
amiloride-sensitive cation channel 5, intestinal FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type III, beta FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type XI, alpha FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type I, beta FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type 10, alpha polypeptide FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type IV, alpha polypeptide FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type V, alpha polypeptide FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type II, beta FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, nonvoltage-gated 1 alpha FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, nonvoltage-gated 1 gamma FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, nonvoltage-gated 1 beta FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type XI, alpha FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, nonvoltage-gated 1, gamma FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, nonvoltage-gated 1, delta FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, nonvoltage-gated 1 alpha FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type X, alpha FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type IX, alpha FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage gated, type VIII, alpha FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type VII, alpha FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type IV, beta FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type IV, alpha FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type III, alpha FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type II, beta FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type II, alpha 2 FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type I, beta FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
sodium channel, voltage-gated, type I, alpha FLUOXETINE Sodium Channel, Site 2 100% .09uM .082uM View
dopamine receptor D3 BENZOTHIAZYL DISULFIDE Dopamine D3 100% .851uM .289uM View
nuclear receptor subfamily 3, group C, member 1 FLUNISOLIDE Glucocorticoid 100% .00533uM .002423uM View
nuclear receptor subfamily 3, group C, member 1 FLUDROCORTISONE ACETATE Glucocorticoid 100% .02uM .009253uM View
adrenergic receptor, alpha 2b BENZOTHIAZYL DISULFIDE Adrenergic alpha2B 100% .162uM .074uM View
adrenergic receptor, alpha 2b THIMEROSAL Adrenergic alpha2B 100% .187uM .085uM View
dopamine receptor D3 THIMEROSAL Dopamine D3 100% .085uM .029uM View
adrenergic receptor, alpha 1b CARVEDILOL Adrenergic alpha1B 100% .003551uM .001966uM View
5-hydroxytryptamine (serotonin) receptor 2C CARVEDILOL Serotonin 5-HT2C 100% .115uM .06uM View
5-hydroxytryptamine (serotonin) receptor 2C CLOMIPRAMINE Serotonin 5-HT2C 100% .034uM .018uM View
adrenergic receptor, alpha 1b CLOZAPINE Adrenergic alpha1B 100% .006487uM .003591uM View
cholinergic receptor, muscarinic 1 CLOZAPINE Muscarinic M1 100% .01uM .002474uM View
5-hydroxytryptamine (serotonin) receptor 2A CLOZAPINE Serotonin 5-HT2A 100% .004195uM .001199uM View
adrenergic receptor, alpha 1a CARVEDILOL Adrenergic alpha1A 100% .007789uM .003153uM View
adrenergic receptor, alpha 1d (Non-specific probe) CARVEDILOL Adrenergic alpha1D 100% .001796uM .000883uM View
adrenergic receptor, alpha 2b CARVEDILOL Adrenergic alpha2C 100% .09uM .013uM View
adrenergic receptor, alpha 2c (Non-specific probe) CARVEDILOL Adrenergic alpha2C 100% .09uM .013uM View
sodium channel, voltage-gated, type IV, beta CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel associated protein 1 CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel associated protein 2 CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type III, beta CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type I, alpha CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type IX, alpha CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type VII, alpha CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
amiloride-sensitive cation channel 5, intestinal CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type III, beta CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type XI, alpha CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type I, beta CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type 10, alpha polypeptide CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type IV, alpha polypeptide CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
sodium channel, voltage-gated, type V, alpha polypeptide CARVEDILOL Sodium Channel, Site 2 100% .455uM .415uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit FLUOXETINE Calcium Channel Type L, Benzothiazepine 100% .827uM .736uM View
calcium channel, voltage-dependent, alpha 1F subunit FLUOXETINE Calcium Channel Type L, Benzothiazepine 100% .827uM .736uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit MEPAZINE Calcium Channel Type L, Phenylalkylamine 100% 1.546uM 1.503uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit MEPAZINE Calcium Channel Type L, Phenylalkylamine 100% 1.546uM 1.503uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit MEPAZINE Calcium Channel Type L, Phenylalkylamine 100% 1.546uM 1.503uM View
calcium channel, voltage-dependent, beta 1 subunit MEPAZINE Calcium Channel Type L, Phenylalkylamine 100% 1.546uM 1.503uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit MEPAZINE Calcium Channel Type L, Phenylalkylamine 100% 1.546uM 1.503uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit MEPAZINE Calcium Channel Type L, Phenylalkylamine 100% 1.546uM 1.503uM View
sodium channel, voltage-gated, type III, alpha QUINACRINE Sodium Channel, Site 2 100% 1.275uM 1.163uM View
sodium channel, voltage-gated, type II, beta QUINACRINE Sodium Channel, Site 2 100% 1.275uM 1.163uM View
sodium channel, voltage-gated, type II, alpha 2 QUINACRINE Sodium Channel, Site 2 100% 1.275uM 1.163uM View
sodium channel, voltage-gated, type I, beta QUINACRINE Sodium Channel, Site 2 100% 1.275uM 1.163uM View
sodium channel, voltage-gated, type I, alpha QUINACRINE Sodium Channel, Site 2 100% 1.275uM 1.163uM View
prostaglandin-endoperoxide synthase 2 ROFECOXIB Cyclooxygenase COX-2 100% .679uM NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) ROFECOXIB Cyclooxygenase COX-2 100% .679uM NoneNone View
sodium channel, voltage-gated, type IV, beta L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel associated protein 1 L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel associated protein 2 L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type III, beta L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type I, alpha L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type IX, alpha L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type VII, alpha L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
amiloride-sensitive cation channel 5, intestinal L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
carbonic anhydrase XIV ISONIAZID Carbonic Anhydrase 9% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type XI, alpha L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type I, beta L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type 10, alpha polypeptide L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type IV, alpha polypeptide L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type V, alpha polypeptide L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type II, beta L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, nonvoltage-gated 1 alpha L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, nonvoltage-gated 1 gamma L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, nonvoltage-gated 1 beta L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type XI, alpha L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, nonvoltage-gated 1, gamma L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, nonvoltage-gated 1, delta L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, nonvoltage-gated 1 alpha L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type X, alpha L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type IX, alpha L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage gated, type VIII, alpha L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type VII, alpha L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type IV, beta L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type IV, alpha L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type III, alpha L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type II, beta L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type II, alpha 2 L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type I, beta L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
sodium channel, voltage-gated, type I, alpha L-744832 Sodium Channel, Site 2 100% .54uM .493uM View
arachidonate 15-lipoxygenase, second type LEVODOPA Lipoxygenase 15-LO 100% 2.258uM NoneNone View
arachidonate 15-lipoxygenase LEVODOPA Lipoxygenase 15-LO 100% 2.258uM NoneNone View
arachidonate 15-lipoxygenase LEVODOPA Lipoxygenase 15-LO 100% 2.258uM NoneNone View
tachykinin receptor 2 L-744832 Tachykinin NK2 100% 1.609uM .536uM View
adrenergic receptor, alpha 2a L-744832 Adrenergic alpha2A 100% .432uM .162uM View
dopamine receptor D3 L-744832 Dopamine D3 100% .028uM .009635uM View
5-hydroxytryptamine (serotonin) receptor 3a TROPISETRON Serotonin 5-HT3 100% .00676uM .001519uM View
5-hydroxytryptamine (serotonin) receptor 3b TROPISETRON Serotonin 5-HT3 100% .00676uM .001519uM View
adrenergic receptor, alpha 1b RISPERIDONE Adrenergic alpha1B 100% .001949uM .001079uM View
adrenergic receptor, alpha 1d (Non-specific probe) RISPERIDONE Adrenergic alpha1D 100% .009995uM .004913uM View
dopamine receptor D3 RISPERIDONE Dopamine D3 100% .024uM .008036uM View
5-hydroxytryptamine (serotonin) receptor 2C RISPERIDONE Serotonin 5-HT2C 100% .015uM .007639uM View
5-hydroxytryptamine (serotonin) receptor 5B TROPISETRON Serotonin 5-HT4 100% .324uM .054uM View
5-hydroxytryptamine (serotonin) receptor 4 TROPISETRON Serotonin 5-HT4 100% .324uM .054uM View
5-hydroxytryptamine (serotonin) receptor 2A RISPERIDONE Serotonin 5-HT2A 100% .000346uM .000099uM View
cholinergic receptor, muscarinic 2 MITOXANTRONE Muscarinic M2 100% .219uM .0779uM View
Protein-tyrosine kinase, Fyn MITOXANTRONE Protein Tyrosine Kinase, Fyn 100% 1.2579uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) MITOXANTRONE Protein Tyrosine Kinase, HER2 Receptor 100% 2.0352uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) MITOXANTRONE Protein Tyrosine Kinase, HER2 Receptor 100% 2.0352uM NoneNone View
adrenergic receptor, beta 2 PROPRANOLOL Adrenergic beta2 100% .001116uM .000767uM View
sodium channel, voltage-gated, type VII, alpha BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type IV, beta BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type IV, alpha BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type III, alpha BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type II, beta BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type II, alpha 2 BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type I, beta BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
sodium channel, voltage-gated, type I, alpha BOPINDOLOL Sodium Channel, Site 2 100% .601uM .548uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 SERTRALINE Serotonin Transporter 100% .000141uM .000075uM View
adrenergic receptor, alpha 2b SERTRALINE Adrenergic alpha2B 100% .1814uM .0828uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 SERTRALINE Dopamine Transporter 100% .0324uM .0258uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 COCCULIN GABAA, Chloride Channel, TBOB 100% .368uM .33uM View
gamma-aminobutyric acid A receptor, gamma 1 COCCULIN GABAA, Chloride Channel, TBOB 100% .368uM .33uM View
gamma-aminobutyric acid A receptor, pi COCCULIN GABAA, Chloride Channel, TBOB 100% .368uM .33uM View
AT hook, DNA binding motif, containing 1 (DBSS) COCCULIN GABAA, Chloride Channel, TBOB 100% .368uM .33uM View
gamma-aminobutyric acid A receptor, theta COCCULIN GABAA, Chloride Channel, TBOB 100% .368uM .33uM View
gamma-aminobutyric acid A receptor, gamma 2 COCCULIN GABAA, Chloride Channel, TBOB 100% .368uM .33uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 COCCULIN GABAA, Chloride Channel, TBOB 100% .368uM .33uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 COCCULIN GABAA, Chloride Channel, TBOB 100% .368uM .33uM View
gamma-aminobutyric acid A receptor, alpha 2 COCCULIN GABAA, Chloride Channel, TBOB 100% .368uM .33uM View
gamma-aminobutyric acid A receptor, alpha 1 COCCULIN GABAA, Chloride Channel, TBOB 100% .368uM .33uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 COCCULIN GABAA, Chloride Channel, TBOB 100% .368uM .33uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 COCCULIN GABAA, Chloride Channel, TBOB 100% .368uM .33uM View
gamma-aminobutyric acid A receptor, delta COCCULIN GABAA, Chloride Channel, TBOB 100% .368uM .33uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 COCCULIN GABAA, Chloride Channel, TBOB 100% .368uM .33uM View
adrenergic receptor, alpha 2b RISPERIDONE Adrenergic alpha2B 100% .026uM .012uM View
adrenergic receptor, alpha 2b RISPERIDONE Adrenergic alpha2C 100% .009557uM .001389uM View
adrenergic receptor, alpha 2c (Non-specific probe) RISPERIDONE Adrenergic alpha2C 100% .009557uM .001389uM View
histamine receptor H 2 RISPERIDONE Histamine H2 100% 1.483uM 1.458uM View
adrenergic receptor, alpha 1a RISPERIDONE Adrenergic alpha1A 100% .000989uM .0004uM View
adrenergic receptor, alpha 2a RISPERIDONE Adrenergic alpha2A 100% .009674uM .003628uM View
sodium channel, voltage-gated, type IV, beta QUINACRINE Sodium Channel, Site 2 100% 1.275uM 1.163uM View
sodium channel associated protein 1 QUINACRINE Sodium Channel, Site 2 100% 1.275uM 1.163uM View
sodium channel associated protein 2 QUINACRINE Sodium Channel, Site 2 100% 1.275uM 1.163uM View
sodium channel, voltage-gated, type III, beta QUINACRINE Sodium Channel, Site 2 100% 1.275uM 1.163uM View
sodium channel, voltage-gated, type I, alpha QUINACRINE Sodium Channel, Site 2 100% 1.275uM 1.163uM View
sodium channel, voltage gated, type VIII, alpha SAQUINAVIR Sodium Channel, Site 2 100% .755uM .677uM View
sodium channel, voltage-gated, type VII, alpha SAQUINAVIR Sodium Channel, Site 2 100% .755uM .677uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) SAQUINAVIR Sodium Channel, Site 2 100% .755uM .677uM View
sodium channel, voltage-gated, type IV, beta SAQUINAVIR Sodium Channel, Site 2 100% .755uM .677uM View
sodium channel, voltage-gated, type IV, alpha SAQUINAVIR Sodium Channel, Site 2 100% .755uM .677uM View